Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Molecular Templates Inc. (MTEM)

8.11   0.32 (4.11%) 05-24 16:00
Open: 7.84 Pre. Close: 7.79
High: 8.4899 Low: 7.79
Volume: 129,342 Market Cap: 298M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 8.5 - 8.533 8.533 - 8.566
Low: 7.709 - 7.746 7.746 - 7.783
Close: 8.049 - 8.107 8.107 - 8.165

Technical analysis

as of: 2019-05-26 10:12:36 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 9.92     One year: 11.58
Support: Support1: 6.98    Support2: 6.04
Resistance: Resistance1: 8.49    Resistance2: 9.92
Pivot: 7.44
Moving Average: MA(5): 7.72     MA(20): 7.37
MA(100): 5.68     MA(250): 5.29
MACD: MACD(12,26): 0.36     Signal(9): 0.33
Stochastic oscillator: %K(14,3): 82.99     %D(3): 80.20
RSI: RSI(14): 67.14
52-week: High: 8.49  Low: 3.19  Change(%): 15.4
Average Vol(K): 3-Month: 8357  10-Days: 9773

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
MTEM has closed above the upper band by 0.4%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 14% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 06 May 2019 16:13:40 Z
Will Molecular Templates (MTEM) Report Negative Q1 Earnings? What You Should Know

Thu, 04 Apr 2019 16:09:14 Z
The Zacks Analyst Blog Highlights: Alpine, Actinium, Molecular Templates, Tricida and Otonomy

Wed, 03 Apr 2019 15:05:41 Z
Small Drugmakers Outperforming the Bigshots: 7 Stocks to Buy

Wed, 03 Apr 2019 14:04:53 Z
Will Molecular Templates Continue to Surge Higher?

Fri, 28 Sep 2018 16:21:01 Z
Friday 9/28 Insider Buying Report: MTEM, CBNK

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 36.77
Shares Float (M) 30.95
% Held by Insiders
% Held by Institutions 46.00
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -0.330
EPS Est. Current Year -0.740
EPS Est. Next Year -0.780
EPS Est. Next Quarter
Forward EPS 1.#IO
Book Value (p.s.) 2.980
PEG Ratio
Profit Margin
Operating Margin -142.67
Return on Assets (ttm) -25.2
Return on Equity (ttm) -34.5
Qtrly Rev. Growth 1353.9
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -6.46
Levered Free Cash Flow (M) -2.52

Stock Valuations

P/E -24.58
P/E Growth Ratio 0.04
P/BV 2.72
P/S 480975296.00
P/CF -46.16

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2017-08-02
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.